Head of U of M Masonic Cancer Care

Maggie Trenary will introduce

I am a medical oncologist with a specialty in breast cancer. My laboratory has been interested in the regulation of cancer cells by insulin-like growth factors (IGFs) and insulin. I also maintain an active clinical practice in the medical management of breast cancer. As part of my clinical care, I serve as the site principal investigator on several clinical trials that employ experimental therapies targeted against IGF receptors and the PI3K pathway. I am chair of the Agent Selection Committee of I-SPY2, and I also serve on the Executive Committee of this trial designed to validate investigational therapies in the neoadjuvant treatment of breast cancer. I have been the director of the Masonic Cancer Center since 2007. I have maintained these clinical, translational, and research activities to best identify strategies for improved outcomes in cancer.